Media Release

28.03.2024

SER concludes investigation concerning Kinarus Therapeutics Holding Ltd

On 28 March 2024, SIX Exchange Regulation AG (SER) concluded the investigation against Kinarus Therapeutics Holding Ltd due to a potential violation of the rules on ad hoc publicity.

On 19 May 2023, SER initiated an investigation against Kinarus Therapeutics Holding Ltd. The investigation was initiated in connection with a potential violation of the rules on ad hoc publicity.

Based on the findings of the investigation, SER concluded that the potential violation will not be further pursued. With the conclusion of the investigation, the sanction proceedings are terminated.